Chemokine Signaling Defects in Human Immunodeficiency
Chemokine Signaling Defects in Human Immunodeficiency
批准号:
6847372
负责人:
GEORGE A DIAZ
金额:
$13.41万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-01 至 2009-02-28
中文摘要
WHIM综合征是一种常染色体显性遗传疾病,
中性粒细胞减少症、可变T细胞缺乏症和不寻常的人乳头瘤病毒感染易感性。
对患有该疾病的患者的分子遗传学研究已经将该性状位点定位于染色体2 q21,并揭示了编码趋化因子受体CXCR 4的基因中的截短突变。通过突变受体的信号传导在患者来源的淋巴母细胞样细胞中增强,与激活机制一致。由于受体及其配体在感染过程中进入HIV细胞以及在B细胞发育和淋巴组织组织形成中的作用,因此对其进行了充分的研究。受体的缺乏损害早期B细胞存活,但携带截短CXCR 4受体的患者中的淋巴细胞缺陷不是简单的定量的,提高了不能迁移到适当的发育区室和/或成熟缺陷的可能性。该提案将集中于在表达突变CXCR 4受体的人类和遗传修饰小鼠细胞中确定截短突变在趋化性、信号转导和β-抑制蛋白介导的受体内化水平上的作用。CXCL 12激活CXCR 4后的细胞内信号传导是复杂的,涉及多种效应物。初步证据表明,G-蛋白偶联和ERK 1/2信号转导的调节在WHIM综合征疾病细胞中受损。将在成熟的不同阶段的B细胞中进行涉及CXCR 4信号传导和趋化性的信号传导途径的生物化学分析。体外研究将与CXCR 4突变对淋巴器官发育的体内影响的测定相结合。除了提供对疾病病理生理学的了解外,
得到的数据将提供关于受体尾结构域在细胞凋亡中的作用的额外信息。
受体反应性的发育调节。拟议的研究与计划项目申请的项目2共享,重点关注免疫缺陷疾病中低丙种球蛋白血症的机制以及迁移缺陷在疾病病理生理学中的可能作用。
英文摘要
WHIM syndrome is an autosomal dominant disease causing hypogammaglobulinernia, congenital
neutropenia, variable T cell deficiency, and an unusual predisposition to human papillomavirus infection.
Molecular genetic studies in patients with the disease have localized the trait locus to chromosome 2q21 and revealed truncating mutations in the gene encoding the chemokine receptor CXCR4. Signaling through the mutant receptors was enhanced in patient-derived lymphoblastoid cells, consistent with an activating mechanism. The receptor and its ligand are well studied because of their roles in HIV cell entry during infection and in B cell development and lymphoid tissue organization. Absence of the receptor compromises early B cell survival, but lymphocyte defects in patients carrying truncated CXCR4 receptors are not simply quantitative, raising the possibility of failure to migrate to the appropriate developmental compartment and/or maturation defects. This proposal will focus on establishing the effect of truncation mutations at the level of chemotaxis, signal transduction, and beta-arrestin-mediated receptor internalization in human and genetically modified murine cells expressing mutant CXCR4 receptors. Intracellular signaling following CXCR4 activation by CXCL12 is complex, involving multiple effectors. Preliminary evidence suggests that regulation of G-protein-coupled and ERK1/2 signaling is impaired in WHIM syndrome disease cells. Biochemical analysis of signaling pathways implicated in CXCR4 signaling and chemotaxis will be performed in B cells at distinct stages of maturation. In vitro studies will be coupled to determination of the in vivo effect of CXCR4 mutations on lymphoid organ development. In addition to providing insight into the disease pathophysiology, the
resulting data will provide additional information on the role of the receptor tail domain in the
developmental regulation of receptor responsiveness. The proposed studies share with Project 2 of the Program Project application a focus on mechanisms of hypogammaglobulinemia in immunodeficiency diseases and the possible role of migration defects in disease pathophysiology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LONGITUDINAL STUDY OF UREA CYCLE DISORDERS
-
批准号:7953693
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2009
-
负责人:GEORGE A DIAZ
-
依托单位:
GT4P COMPARED TO SODIUM PHENYLBUTYRATE IN UREA CYCLE DISORDERS
-
批准号:7953719
-
项目类别:
-
资助金额:$0.64万
-
财政年份:2009
-
负责人:GEORGE A DIAZ
-
依托单位:
KENNY CAFFEY SYNDROME: BONE SCLEROSIS AND HYPOCALCEMIA
-
批准号:2828640
-
项目类别:
-
资助金额:$12.96万
-
财政年份:1999
-
负责人:GEORGE A DIAZ
-
依托单位:
KENNY CAFFY SYNDROME: BONE SCLEROSIS AND HYPOCALCEMIA
-
批准号:6644201
-
项目类别:
-
资助金额:$12.96万
-
财政年份:1999
-
负责人:GEORGE A DIAZ
-
依托单位:
KENNY CAFFEY SYNDROME: BONE SCLEROSIS AND HYPOCALCEMIA
-
批准号:6387357
-
项目类别:
-
资助金额:$12.96万
-
财政年份:1999
-
负责人:GEORGE A DIAZ
-
依托单位:
KENNY CAFFY SYNDROME: BONE SCLEROSIS AND HYPOCALCEMIA
-
批准号:6520619
-
项目类别:
-
资助金额:$12.96万
-
财政年份:1999
-
负责人:GEORGE A DIAZ
-
依托单位:
KENNY CAFFEY SYNDROME: BONE SCLEROSIS AND HYPOCALCEMIA
-
批准号:6182110
-
项目类别:
-
资助金额:$12.96万
-
财政年份:1999
-
负责人:GEORGE A DIAZ
-
依托单位:
Chemokine Signaling Defects in Human Immunodeficiency
-
批准号:7063476
-
项目类别:
-
资助金额:$25.89万
-
财政年份:--
-
负责人:GEORGE A DIAZ
-
依托单位:
Chemokine Signaling Defects in Human Immunodeficiency
-
批准号:7212179
-
项目类别:
-
资助金额:$26.44万
-
财政年份:--
-
负责人:GEORGE A DIAZ
-
依托单位:
Chemokine Signaling Defects in Human Immunodeficiency
-
批准号:7367088
-
项目类别:
-
资助金额:$25.69万
-
财政年份:--
-
负责人:GEORGE A DIAZ
-
依托单位:
海外基金